Clinical Trial Update: Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for a vaccine targeting atherosclerosis in overweight or obese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Drugs mentioned

• Vaccine Against Atherosclerosis

Snippet

Sponsor: Immunitor LLC | Conditions: Atherosclerosis | Phase 3 | Status: UNKNOWN